RNF213 p.R4810K Variant Increases the Risk of Vasospastic Angina
暂无分享,去创建一个
K. Nishimura | M. Ihara | T. Noguchi | S. Ogata | T. Yoshimoto | Hiroyuki Ishiyama | Tomotaka Tanaka | Yoshihiro Asano | A. Koizumi | Atsushi Takahashi
[1] K. Node,et al. JCS/CVIT/JCC 2023 Guideline Focused Update on Diagnosis and Treatment of Vasospastic Angina (Coronary Spastic Angina) and Coronary Microvascular Dysfunction. , 2023, Circulation journal : official journal of the Japanese Circulation Society.
[2] T. Park,et al. Systemic vasculopathy associated with an RNF213 p.Arg4810Lys variant in moyamoya disease: A review , 2022, Precision and Future Medicine.
[3] G. Steinberg,et al. Moyamoya disease: diagnosis and interventions , 2022, The Lancet Neurology.
[4] H. Aburatani,et al. Population-specific and trans-ancestry genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease , 2020, Nature Genetics.
[5] S. Miyamoto,et al. Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease , 2017, PloS one.
[6] S. Kinlay. Coronary artery spasm as a cause of angina. , 2014, Circulation.